Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use during the high-risk transition into university life. Digital tools like Minder are being evaluated because they can reach large student populations at low cost and are generally well accepted by young adults. Results from this trial provide direct clinical evidence on whether app-based interventions can meaningfully improve outcomes in this vulnerable group.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial evaluates a scalable digital intervention designed to address mental health and substance use disorders during a critical developmental period when these conditions typically emerge in university populations. The study’s findings provide evidence for whether mobile health technologies can effectively reduce symptom burden and substance use in young adults, informing clinical integration of digital therapeutics into campus mental health services. Positive results would support adoption of app-based interventions as cost-effective adjuncts to traditional counseling services for resource-limited university health centers.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 The Minder app study addresses a genuine clinical need, as university students do represent a vulnerable population for concurrent mental health and substance use concerns, and digital interventions offer practical scalability that traditional office-based care cannot match. However, several important caveats merit consideration: the study population is self-selected (likely those already willing to engage with digital tools), the duration of follow-up and sustainability of benefits remain unclear from the available abstract, and mobile app efficacy often differs substantially between controlled trial conditions and real-world implementation where adherence and engagement typically decline. Additionally, cannabis use was not specified as a primary focus of the Minder intervention, so direct applicability to cannabis-related concerns in this population is uncertain. For clinicians, this research suggests that offering digital mental health tools as a complement to standard care may be reasonable for university-age patients, particularly those already inclined toward digital solutions, but should not replace traditional assessment and individualized treatment planning, especially for students with more severe or complex presentations.
| |